Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Erythropoietin Drugs Market – Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 – 2025

Report Description

Global Erythropoietin Drugs Market: Snapshot

Erythropoietin is a hormone which produce inside the body from kidney. EPO helps in the development of RBC inside the body and high number of RBC increases the level of hemoglobin in the blood which transport the oxygen in every part of the body. The market for these erythropoietin drugs is anticipated to grow significantly in the forecast period, owing to the rising prevalence of chronic diseases, focus of government and non-government organizations on creating awareness, research and development grants, and fee waivers and tax credits offered, among others.  

Global Erythropoietin Drugs Market: Research Methodologies

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of drugs employed in the treatment of chronic diseases in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for drug class, drug type, drug application, distribution channel, and geography for the period 2015 to 2025, considering the macro and micro environmental factors. The revenue generated from each drug class, drug type, drug application, and distribution channel was calculated by considering the prevalence of chronic diseases, erythropoietin drug approvals, regulatory procedures, and the awareness of chronic diseases across all the geographies.

Global Erythropoietin Drugs Market: Segmentation

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on drug class, drug type, drug application, distribution channel, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the erythropoietin drugs market in the current and future scenario. The report also provides Porter’s five forces analysis, the acquisitions timeline of erythropoietin drug companies, SWOT analysis of the market, regulatory scenario, comparative analysis of erythropoietin drug policies, chronic diseases prevalence, pricing scenario of the erythropoietin drugs, major selling erythropoietin drugs, and drug exclusivity of certain of the erythropoietin drugs,  for the market.

Global Erythropoietin Drugs Market: Competitive Landscape

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The study also covers detailed country analysis contributing majorly in the erythropoietin drugs market.

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Companies profiled in the erythropoietin drugs market report are Amgen Inc., Novartis AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Merck & Co., Inc., Johnson & Johnson, Wockhardt Ltd., Pfizer, Inc., Biocon Ltd., and Teva Pharmaceutical Industries Ltd. among others.

The Erythropoietin Drugs Market has been segmented as follows:

  • Erythropoietin Drugs Market, by Drug Class, Revenue (US$ Mn) 2015-2025
    • Epoetin Alfa
    • Epoetin Beta
    • Darbepoetin Alfa
    • Others
       
  • Erythropoietin Drugs Market, by Drug Type, Revenue (US$ Mn) 2015-2025
    • Biologics
    • Biosimilar
       
  • Erythropoietin Drugs Market, by Drug Application, Revenue (US$ Mn) 2015-2025
    • Cancer
    • Renal Disease
    • Hematology
    • Neurology
    • Others (Surgery, Wound healing, etc.)
       
  • Erythropoietin Drugs Market, by Drug Application, Revenue (US$ Mn) 2015-2025
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
       
  • Erythropoietin Drugs Market Revenue, by Geography (US$ Mn), 2015-2025
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • Spain
      • France
      • Italy
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of LATAM
    • Middle East and Africa
      • GCC Countries
      • Israel
      • South Africa
      • Rest of MEA

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote